118 related articles for article (PubMed ID: 27427307)
1. Management of postprandial glucose: Recommended targets and treatment with biphasic insulin.
Liebl A
Prim Care Diabetes; 2016 Dec; 10(6):391-397. PubMed ID: 27427307
[TBL] [Abstract][Full Text] [Related]
2. Visualization of Blood Glucose Fluctuations Using Continuous Glucose Monitoring in Patients Undergoing Hemodialysis.
Mori K; Emoto M; Abe M; Inaba M
J Diabetes Sci Technol; 2019 Mar; 13(2):413-414. PubMed ID: 30580579
[No Abstract] [Full Text] [Related]
3. Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial.
Xu S; Liu X; Ming J; Ji Q
Trials; 2016 Mar; 17():160. PubMed ID: 27009108
[TBL] [Abstract][Full Text] [Related]
4. Comment on "Management of postprandial glucose: Recommended targets and treatment with biphasic insulin".
Kalra S
Prim Care Diabetes; 2016 Dec; 10(6):459. PubMed ID: 27497876
[No Abstract] [Full Text] [Related]
5. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
[TBL] [Abstract][Full Text] [Related]
6. A comparison of pharmacokinetics and pharmacodynamics of insulin aspart, biphasic insulin aspart 70, biphasic insulin aspart 50, and human insulin: a randomized, quadruple crossover study.
Ma Z; Parkner T; Frystyk J; Laursen T; Lauritzen T; Christiansen JS
Diabetes Technol Ther; 2012 Jul; 14(7):589-95. PubMed ID: 22519735
[TBL] [Abstract][Full Text] [Related]
7. Special section on artificial intelligence for diabetes.
López B; Martin C; Viñas PH
Artif Intell Med; 2018 Apr; 85():26-27. PubMed ID: 28943334
[No Abstract] [Full Text] [Related]
8. Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications.
Alvarez CA; Lingvay I; Vuylsteke V; Koffarnus RL; McGuire DK
Clin Pharmacol Ther; 2015 Aug; 98(2):145-61. PubMed ID: 25963811
[TBL] [Abstract][Full Text] [Related]
9. Impact of Blood Glucose Reporting on Glycemic Variability in Veterans With Diabetes.
Mangrum C; Smith L; Shivaswamy V
J Diabetes Sci Technol; 2015 Aug; 9(6):1348-9. PubMed ID: 26285952
[No Abstract] [Full Text] [Related]
10. Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving?
Madsbad S
J Diabetes Complications; 2016 Mar; 30(2):374-85. PubMed ID: 26541075
[TBL] [Abstract][Full Text] [Related]
11. A pilot study to examine the tolerability and device preference in type 1 diabetes of insulin aspart administered by InsuJet compared with subcutaneous injection.
Reutens AT; Balkau B; Cohen N
Diabetes Technol Ther; 2014 Apr; 16(4):235-40. PubMed ID: 24286115
[TBL] [Abstract][Full Text] [Related]
12. Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study.
Balaji V; Balaji MS; Alexander C; Srinivasan A; Suganthi SR; Thiyagarajah A; Seshiah V
Gynecol Endocrinol; 2012 Jul; 28(7):529-32. PubMed ID: 22468861
[TBL] [Abstract][Full Text] [Related]
13. Postprandial plasma glucose effects of once-weekly albiglutide for the treatment of type 2 diabetes.
Matthews JE; Reinhardt RR; Carr MC
Postgrad Med; 2016 May; 128(4):391-7. PubMed ID: 27043162
[TBL] [Abstract][Full Text] [Related]
14. Similar glucose control with basal-bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification.
Malek R; Ajili F; Assaad-Khalil SH; Shinde A; Chen JW; Van den Berg E
Diabetes Metab; 2015 Jun; 41(3):223-30. PubMed ID: 25483023
[TBL] [Abstract][Full Text] [Related]
15. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
16. Diabetes treatment over age 65: Is worse control really better?
Bloomgarden Z; Mende C; Einhorn D; Handelsman Y
J Diabetes; 2017 May; 9(5):428-430. PubMed ID: 28133929
[No Abstract] [Full Text] [Related]
17. Impact of insulins glulisine and aspart on postprandial glycemia after a high-glycemic index meal in children with type 1 diabetes.
Dzygalo K; Szypowska A
Eur J Endocrinol; 2014 Apr; 170(4):539-45. PubMed ID: 24412929
[TBL] [Abstract][Full Text] [Related]
18. Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes.
Tibaldi J
South Med J; 2009 Jan; 102(1):60-6. PubMed ID: 19077774
[TBL] [Abstract][Full Text] [Related]
19. Some specificities in the management of hyperglycemia in patients with diabetic kidney disease.
Dragović T; Marinković D; Kiković S; Pejović J; Hajduković Z
Vojnosanit Pregl; 2016 Sep; 73(9):857-63. PubMed ID: 29320619
[No Abstract] [Full Text] [Related]
20. Hyperglycaemia in acute stroke--to treat or not to treat.
Quinn TJ; Lees KR
Cerebrovasc Dis; 2009; 27 Suppl 1():148-55. PubMed ID: 19342845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
